Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA lays out donanemab concerns, Lilly vigorously defends safety
The docs for Eli Lilly’s donanemab meeting are in: the FDA has concerns about tau PET imaging, the cessation of dosing and the benefit-risk profile.
Annalee Armstrong
Jun 6, 2024 10:55am
Asensus Surgical seals the acquisition deal with Karl Storz
Jun 7, 2024 1:00pm
FDA boosts Medtronic recall of brain surgery navigation software
Jun 7, 2024 12:15pm
Abbott secures EU approval for dual-chamber leadless pacemaker
Jun 7, 2024 11:12am
Rapport upsizes IPO, tacking on $32M
Jun 7, 2024 11:00am
Ipsen, Marengo ink $1.2B biobuck deal to treat cold tumors
Jun 7, 2024 9:15am
Medtech News
Edwards delivers 5-year TAVR safety data focused on women
Jun 6, 2024 2:05pm
Eko Health captures $41M to expand AI stethoscope business
Jun 6, 2024 12:00pm
Moon Surgical's robotic OR helper gets commercial green light
Jun 5, 2024 12:03pm
Radiopharma-focused Telix targets $200M IPO
Jun 5, 2024 10:57am
See More Medtech News